Linda Keeling, CNM in Ranson, WV - Advanced Practice Midwife

Linda Keeling, CNM is a Advanced Practice Midwife based in Ranson, West Virginia. Linda Keeling is licensed to practice in West Virginia (license number 38735) and her current practice location is 203 E 4th Ave, Ranson, West Virginia. She can be reached at her office (for appointments etc.) via phone at (304) 535-6343.

NPI number for Linda Keeling is 1588608848 and her current mailing address is 2500 Foundation Way, Martinsburg, West Virginia. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1588608848.

Contact Information

	Linda Keeling, CNM
	203 E 4th Ave, Ranson, WV 25438-1617
	(304) 535-6343
	(304) 293-6963

Provider's Profile

Full Name	Linda Keeling
Gender	Female
Speciality	Advanced Practice Midwife
Location	203 E 4th Ave, Ranson, West Virginia
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1588608848
Provider Enumeration Date: 06/16/2006
Last Update Date: 01/08/2015

Medical Identifiers

Medical identifiers for Linda Keeling such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1588608848	NPI	-	NPPES
9450038000	Medicaid	WV

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
367A00000X	Advanced Practice Midwife	38735 (West Virginia)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Linda Keeling is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Linda Keeling, CNM 2500 Foundation Way, Martinsburg, WV 25401-9000 Ph: (304) 264-9202	Linda Keeling, CNM 203 E 4th Ave, Ranson, WV 25438-1617 Ph: (304) 535-6343

News Archive

International consortium investigates specific cell signaling process across range of human diseases

Life in the digital age often throws a curveball when the signalling bars on our mobile phones drop or disappear altogether. Similarly, disruptions in the signalling networks of cells within the body can wreak havoc and lead to disease.

Roche completes enrollment in Herceptin SC Phase 3 trial for HER2-positive breast cancer

Halozyme Therapeutics, Inc. today announced that Roche has completed patient enrollment for the pivotal Phase 3 study of Herceptin SC (trastuzumab subcutaneous), a subcutaneous formulation that uses Halozyme's Enhanze™ technology (rHuPH20, recombinant human hyaluronidase).

Diabetes and high blood sugar impose negative effect on cognitive, decision-making skills

MINNEAPOLIS - In just two years, people with type 2 diabetes experienced negative changes in their ability to regulate blood flow in the brain, which was associated with lower scores on tests of cognition skills and their ability to perform their daily activities, according to a new study published in the July 8, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

Inviragen initiates first clinical trial of DENVax vaccine to protect against dengue fever

Inviragen has announced the initiation of the first clinical trial of its vaccine to protect against dengue fever. The trial, to be conducted at Saint Louis University, is designed to assess the safety of Inviragen's investigational dengue vaccine.

Decoding effects of toxins on embryo development

Changes in gene expression patterns in zebrafish embryos resulting from exposure to environmental toxins can identify the individual toxins at work, according to research published in the online open access journal Genome Biology.

Linda Keeling, CNM - Advanced Practice Midwife in Ranson, WV